Citi Opens 90-Day Positive Catalyst Call on Olema Pharmaceuticals (OLMA) Jan 6, 2026 06:11AM
Olema Pharmaceuticals (OLMA) PT Raised to $60 at Citi, Opens Catalyst Watch Dec 12, 2025 05:54AM
Olema Pharmaceuticals (OLMA) PT Raised to $21 at Citi, Opens Catalyst Watch Aug 12, 2025 04:50AM
Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement Dec 2, 2024 07:33AM
Olema Oncology to Participate in Upcoming Investor Conferences Nov 6, 2024 07:01AM


Feb 14, 2024 07:32AM Citi Downgrades Arvinas Inc. (ARVN) to Neutral, 'we believe risk/reward appears balanced'
Jan 30, 2024 05:03AM Citi Starts Olema Pharmaceuticals (OLMA) at Buy, 'Next-Gen Endocrine Therapy with Potential Across Multiple Lines of Breast Cancer'
Feb 21, 2023 04:30PM Olema Oncology to Participate at Upcoming Investor Conferences